207 related articles for article (PubMed ID: 9146927)
1. Nasal nitric oxide is increased in allergic rhinitis.
Arnal JF; Didier A; Rami J; M'Rini C; Charlet JP; Serrano E; Besombes JP
Clin Exp Allergy; 1997 Apr; 27(4):358-62. PubMed ID: 9146927
[TBL] [Abstract][Full Text] [Related]
2. Nasal nitric oxide and nasal eosinophils decrease with levocetirizine in subjects with perennial allergic rhinitis.
Bautista AP; Eisenlohr CP; Lanz MJ
Am J Rhinol Allergy; 2011; 25(6):383-7. PubMed ID: 22185740
[TBL] [Abstract][Full Text] [Related]
3. The effect of allergic rhinitis on adenosine concentration in exhaled breath condensate.
Vass G; Huszár E; Augusztinovicz M; Baktai G; Barát E; Herjavecz I; Horváth I
Clin Exp Allergy; 2006 Jun; 36(6):742-7. PubMed ID: 16776675
[TBL] [Abstract][Full Text] [Related]
4. Nasal nitric oxide and nasal allergy.
Struben VM; Wieringa MH; Feenstra L; de Jongste JC
Allergy; 2006 Jun; 61(6):665-70. PubMed ID: 16677234
[TBL] [Abstract][Full Text] [Related]
5. The effect of topical fluticasone on nasal nitric oxide levels in a patient with allergic rhinitis.
Vural C; Gungor A
Ear Nose Throat J; 2003 Aug; 82(8):592-7. PubMed ID: 14503095
[TBL] [Abstract][Full Text] [Related]
6. [Intradermal tests using vasomotor agents in allergic rhinitis].
Milosević DN; Janosević LjB; Janosević SB
Srp Arh Celok Lek; 2000; 128(11-12):357-62. PubMed ID: 11337913
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages.
Gosset P; Tillie-Leblond I; Malaquin F; Durieu J; Wallaert B; Tonnel AB
Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930
[TBL] [Abstract][Full Text] [Related]
8. Does nasal breathing cause frictional trauma in allergic rhinitis?
Singh V; Chowdhary R; Chowdhary N
J Assoc Physicians India; 2000 May; 48(5):501-4. PubMed ID: 11273143
[TBL] [Abstract][Full Text] [Related]
9. Nasal nitric oxide: longitudinal reproducibility and the effects of a nasal allergen challenge in patients with allergic rhinitis.
Boot JD; de Kam ML; Mascelli MA; Miller B; van Wijk RG; de Groot H; Cohen AF; Diamant Z
Allergy; 2007 Apr; 62(4):378-84. PubMed ID: 17362248
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory and oxidative stress biomarkers in allergic rhinitis: the effect of smoking.
Tanou K; Koutsokera A; Kiropoulos TS; Maniati M; Papaioannou AI; Georga K; Zarogiannis S; Gourgoulianis KI; Kostikas K
Clin Exp Allergy; 2009 Mar; 39(3):345-53. PubMed ID: 19187324
[TBL] [Abstract][Full Text] [Related]
11. Humming-induced release of nasal nitric oxide for assessment of sinus obstruction in allergic rhinitis: pilot study.
Maniscalco M; Sofia M; Weitzberg E; De Laurentiis G; Stanziola A; Rossillo V; Lundberg JO
Eur J Clin Invest; 2004 Aug; 34(8):555-60. PubMed ID: 15305890
[TBL] [Abstract][Full Text] [Related]
12. Thresholds in nasal histamine challenge in patients with allergic rhinitis, patients with hyperreflectory rhinopathy, and healthy volunteers.
Wuestenberg EG; Hauswald B; Huettenbrink KB
Am J Rhinol; 2004; 18(6):371-5. PubMed ID: 15706984
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive methods for the detection of upper and lower airway inflammation in atopic children.
Profita M; La Grutta S; Carpagnano E; Riccobono L; Di Giorgi R; Bonanno A; Pace E; Bonsignore G; Bousquet J; Vignola AM; Gjomarkaj M
J Allergy Clin Immunol; 2006 Nov; 118(5):1068-74. PubMed ID: 17088131
[TBL] [Abstract][Full Text] [Related]
14. Nasal nitric oxide, the guardian of paranasal sinuses, is paradoxically increased by high doses of intravenous glucocorticoids.
Degano B; Têtu L; Serrano E; Didier A; Arnal JF
Allergy; 2005 Oct; 60(10):1323-6. PubMed ID: 16135002
[TBL] [Abstract][Full Text] [Related]
15. Relationship between fractional exhaled nitric oxide and nasal nitric oxide in airways disease.
Williamson PA; Vaidyanathan S; Clearie K; Stewart M; Lipworth BJ
Ann Allergy Asthma Immunol; 2010 Aug; 105(2):162-7. PubMed ID: 20674828
[TBL] [Abstract][Full Text] [Related]
16. Relationship between nasal nitric oxide concentration and nasal airway resistance.
Ferguson EA; Eccles R
Rhinology; 1997 Sep; 35(3):120-3. PubMed ID: 9403942
[TBL] [Abstract][Full Text] [Related]
17. In vitro diagnosis of chronic nasal inflammation.
Kramer MF; Burow G; Pfrogner E; Rasp G
Clin Exp Allergy; 2004 Jul; 34(7):1086-92. PubMed ID: 15248854
[TBL] [Abstract][Full Text] [Related]
18. Nasal nitric oxide and its relationship to nasal symptoms, smoking and nasal nitrate.
Olin AC; Hellgren J; Karlsson G; Ljungkvist G; Nolkrantz K; Torén K
Rhinology; 1998 Sep; 36(3):117-21. PubMed ID: 9830675
[TBL] [Abstract][Full Text] [Related]
19. Clinical application of nasal nitric oxide measurement.
Carraro S; Cutrone C; Cardarelli C; Zanconato S; Baraldi E
Int J Immunopathol Pharmacol; 2010; 23(1 Suppl):50-2. PubMed ID: 20152081
[TBL] [Abstract][Full Text] [Related]
20. Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis.
Lieberman P; Kaliner MA; Wheeler WJ
Curr Med Res Opin; 2005 Apr; 21(4):611-8. PubMed ID: 15899111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
